Latest Insider Transactions at Tekla World Healthcare Fund (THW)
This section provides a real-time view of insider transactions for Tekla World Healthcare Fund (THW). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Tekla World Healthcare Fund to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Tekla World Healthcare Fund's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 14
2024
|
Bill Maher Director |
BUY
Open market or private purchase
|
Direct |
1,000
+50.0%
|
$13,000
$13.03 P/Share
|
|
Jul 16
2024
|
Rose Di Martino Director |
BUY
Open market or private purchase
|
Direct |
1,000
+50.0%
|
$13,000
$13.31 P/Share
|
|
Apr 09
2024
|
Kathleen Goetz Director |
BUY
Open market or private purchase
|
Direct |
200
+16.43%
|
$2,400
$12.53 P/Share
|
|
Jan 02
2024
|
Todd Reit Director |
BUY
Open market or private purchase
|
Direct |
1,000
+50.0%
|
$11,000
$11.94 P/Share
|
|
Mar 23
2022
|
Kathleen Goetz Director |
BUY
Open market or private purchase
|
Direct |
103
+11.2%
|
$1,442
$14.52 P/Share
|
|
Jan 26
2022
|
Kathleen Goetz Director |
BUY
Open market or private purchase
|
Direct |
714
+50.0%
|
$9,996
$14.6 P/Share
|
|
Apr 06
2021
|
Thomas M Kent Director |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
600
+20.0%
|
$8,400
$14.26 P/Share
|
|
Apr 06
2021
|
Daniel R Omstead President |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
6,442
+17.31%
|
$90,188
$14.26 P/Share
|
|
Apr 06
2021
|
William S Reardon Director |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
486
+19.98%
|
$6,804
$14.26 P/Share
|
|
Apr 06
2021
|
Lucinda H Stebbins Director |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
250
+20.0%
|
$3,500
$14.26 P/Share
|
|
Apr 06
2021
|
Jeffrey Allen Bailey Director |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
245
+20.0%
|
$3,430
$14.26 P/Share
|
|
Feb 25
2021
|
William S Reardon Director |
BUY
Open market or private purchase
|
Direct |
1,460
+50.0%
|
$24,820
$17.14 P/Share
|
|
Feb 19
2021
|
Lucinda H Stebbins Director |
BUY
Open market or private purchase
|
Direct |
750
+50.0%
|
$12,000
$16.8 P/Share
|